Press Releases

and/or
565 News Releases found
Media Advisory
A collaborative effort among cancer experts from Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College has yielded an interesting association: Obesity prior to diagnosis is associated with a five-fold increase in the risk of death from early-stage squamous cell carcinoma of the tongue.
David Scheinberg
Memorial Sloan Kettering and Eureka Therapeutics recently entered into a licensing agreement with Novartis to develop a unique monoclonal antibody.
Pictured: Jedd Wolchok and Alexander Rudensky
Media Advisory
Memorial Sloan Kettering Cancer Center, along with five other elite academic institutions, will share an unprecedented total of $540 million in new financial support from Ludwig Cancer Research.
Pictured: Ross Levine
FoundationOne Heme was developed using technology, methods and computational algorithms developed by Foundation Medicine, combined with Memorial Sloan Kettering’s deep and vast expertise in clinical and laboratory research into hematologic malignancies.
Pictured: Michael Foley
Michael A. Foley, PhD, has been selected to lead the Tri-Institutional Therapeutics Discovery Institute, Inc., a pioneering collaboration of Weill Cornell Medical College, The Rockefeller University and Memorial Sloan Kettering Cancer Center.
Pictured: Joan Massagué
Renowned cancer biologist Joan Massagué, PhD, has been named Director of the Sloan Kettering Institute, one of the most dynamic and robust cancer research programs in the United States, and the research arm of Memorial Sloan Kettering Cancer Center.
Pictured: Richard Barakat
Memorial Sloan Kettering Cancer Center has announced the appointment of surgical oncologist Richard Barakat to the new position of Deputy Physician-in-Chief for the Memorial Sloan Kettering Regional Care Network and Alliance.
Memorial Sloan Kettering Cancer Center, The Rockefeller University and Weill Cornell Medical College have formed the pioneering Tri-Institutional Therapeutics Discovery Institute, Inc. and have partnered with Takeda Pharmaceutical Company, Ltd.
Pictured: Levi A. Garraway; Duojia (DJ) Pan; and Simon J. Boulton
Memorial Sloan Kettering Cancer Center has named three investigators as recipients of this year’s Paul Marks Prize for Cancer Research.
Memorial Sloan Kettering Cancer Center is leading an innovative initiative to reduce cancer and cardiovascular health disparities in South Asian immigrant communities in the United States.